Kymera Therapeutics, Inc. (KYMR) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kymera Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.993 -- 00:00:05.961 Good day, everyone. My name is Kahayalani, and I will be your conference operator today. 00:00:05.961 -- 00:00:11.150 At this time, I would like to welcome you to the Chimera Therapeutics fourth 00:00:11.150 -- 00:00:16.278 quarter 2025 results call. All lines have been placed on mute to prevent 00:00:16.278 -- 00:00:21.385 any background noise. After the speaker's remarks, there will be a question and answer 00:00:21.385 -- 00:00:26.490 session. If you'd like to ask a question during this time, and if you've joined via 00:00:26.490 -- 00:00:31.496 the webinar, please use the raise hand icon, which can be found at the bottom of your 00:00:31.496 -- 00:00:36.561 webinar application. If you've joined by phone, please dial star 9 on 00:00:36.561 -- 00:00:41.506 your keypad to raise your hand. At this time, I'd like to turn the call over to Justine 00:00:41.506 -- 00:00:45.969 Konigsberg, Vice President, Investor Relations. 00:00:46.150 -- 00:00:50.756 Good morning and welcome to Chimera Therapeutics quarterly update conference call. 00:00:50.756 -- 00:00:55.461 Joining me today are Noah Meinolfi, our founder, president, chief executive officer, 00:00:55.461 -- 00:01:00.968 Jared Golub, our chief medical officer, and Bruce Jacobs, our chief financial officer. 00:01:00.968 -- 00:01:04.612 Following our prepared remarks, we will open the call for questions from our publishing 00:01:04.612 -- 00:01:09.819 analysts. Please use the raise hand icon to indicate that you'd like to ask a question, 00:01:09.819 -- 00:01:13.563 and we ask that you limit your question to one and a brief follow-up so we can accommodate 00:01:13.563 -- 00:01:18.608 everyone. Before we begin, I would like to remind you that today's discussion will include 00:01:18.60...